Techmah Cmf Llc Receives FDA 510(k) Approval for New tmCMF Solution

TechMah CMF LLC, an innovative medical device company, is pleased to announce the FDA 510(k) approval of its cutting-edge medical device, the tmCMF Solution. This approval marks a significant milestone for the company, reaffirming its dedication to advancing healthcare through advanced technology.

The tmCMF Solution is a collection of personalized product solutions for trauma and reconstruction procedures in the mandible and midface. The solution is comprised of Surgeon Review Tool (SRT) software and maxillofacial and mandibular surgical instruments, including surgical guides, anatomical models and dental splints. The surgical instruments are patient-specific devices and are designed using CT and dental scan patient image data. The SRT software is an intuitive, surgeon-driven digital solution that unites patient-focused healthcare and artificial intelligence to deliver customized preoperative plans and 3D-printed instrumentation to global surgeons and patients.

"We are excited to announce the successful 510(k) medical device approval for the tmCMF Solution, which we believe will be a transformative advancement, bridging medical imaging and surgical planning," said Dr. Mohamed Mahfouz, president and CEO of TechMah CMF and professor of biomedical engineering at The University of Tennessee, Knoxville. "We are committed to advancing healthcare through ingenuity, and this approval underscores our dedication to making a tangible difference in patient care."

The tmCMF Solution will transform how healthcare professionals approach maxillofacial and mandibular surgery. Its advanced capabilities can serve as a preoperative tool for simulating and evaluating surgical treatments, providing surgeons with greater precision and confidence in their procedures.

With commercial release anticipated in Q3 2024, the tmCMF Solution promises to provide medical professionals with the options they need to deliver higher-quality care and improve patient outcomes.

TechMah CMF LLC was founded in 2021 by Dr. Mahfouz, Dr. Emam E. Abdel Fatah and Dr. Gary To, all industry leaders in biomedical research. The founders were instrumental in the development of the surgical tmCMF Solution.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!